FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
Philly Council slams Trump after federal funding freeze memo causes ‘mass hysteria’ for local leaders | City Council roundup
Philadelphia City Council members on Thursday criticized President Donald Trump following a week of chaos for state and local governments as officials responded to the whiplash of the White House ...
WBUR2h
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...
Judge grants extradition of alleged drug smuggler Hussein Chamas
The accused drug smuggler is to be extradited to NSW after he was arrested on a yacht on Australia Day allegedly trying to ...
Our Community: Applications open for Youth Harm Reduction Award, Indigenous communities get grants
Applications for the 2025 Youth Harm Reduction Award are now open for youth in the Island Health region who have worked on a harm-reduction project ...
wacotrib4d
NanoViricides Engages CRO for Phase II Clinical Trial
SHELTON, CT / / January 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to ...